TY - JOUR
T1 - Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P
AU - Byk, Gerardo
AU - Halle, David
AU - Zeltser, Irena
AU - Bitan, Gal
AU - Selinger, Zvi
AU - Gilon, Chaim
PY - 1996/8/2
Y1 - 1996/8/2
N2 - The application of the concept of backbone cyclization to linear substance P (SP) analogs is presented. We describe the synthesis, characterization, and biological activity of a series of backbone-to-amino- terminus cyclic analogs of the C-terminal hexapeptide of SP. These analogs were designed on the basis of NMR data and molecular modeling of the selective NK-1 analog WS-septide (Ac[Arg6,Pro9]SP6-11). A series of peptides with the general formula: cyclo[-(CH2)(m)-NH-CO-(CH2)(n)-CO-Arg- Phe-Phe-N-]-CH2-CO-Leu-Met-NH2 (n = 2, 3, 6 and m = 2, 3, 4) was synthesized by solid phase methodology using Fmoc chemistry for the main chain and Boc chemistry for the building units [N(α)-(ω-aminoalkyl)Gly] side chains. Cyclization was performed on the resin after removal of the Boc protecting group from the ω-aminoalkyl chain. Cyclic and precyclic analogs were compared. They were purified by HPLC and characterized by mass spectroscopy and NMR. Biological activity and selectivity to the NK-1 neurokinin receptor were found to depend on cyclization and the ring size: The most active and selective analog had a ring of 20 atoms. This analog was found to have enhanced metabolic stability in various tissue preparation compared to WS-septide.
AB - The application of the concept of backbone cyclization to linear substance P (SP) analogs is presented. We describe the synthesis, characterization, and biological activity of a series of backbone-to-amino- terminus cyclic analogs of the C-terminal hexapeptide of SP. These analogs were designed on the basis of NMR data and molecular modeling of the selective NK-1 analog WS-septide (Ac[Arg6,Pro9]SP6-11). A series of peptides with the general formula: cyclo[-(CH2)(m)-NH-CO-(CH2)(n)-CO-Arg- Phe-Phe-N-]-CH2-CO-Leu-Met-NH2 (n = 2, 3, 6 and m = 2, 3, 4) was synthesized by solid phase methodology using Fmoc chemistry for the main chain and Boc chemistry for the building units [N(α)-(ω-aminoalkyl)Gly] side chains. Cyclization was performed on the resin after removal of the Boc protecting group from the ω-aminoalkyl chain. Cyclic and precyclic analogs were compared. They were purified by HPLC and characterized by mass spectroscopy and NMR. Biological activity and selectivity to the NK-1 neurokinin receptor were found to depend on cyclization and the ring size: The most active and selective analog had a ring of 20 atoms. This analog was found to have enhanced metabolic stability in various tissue preparation compared to WS-septide.
UR - http://www.scopus.com/inward/record.url?scp=0029742789&partnerID=8YFLogxK
U2 - 10.1021/jm960154i
DO - 10.1021/jm960154i
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 8759639
AN - SCOPUS:0029742789
SN - 0022-2623
VL - 39
SP - 3174
EP - 3178
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 16
ER -